SCHEMBL4962048

SCHEMBL4962048

[CH2]c1cccc(SCc2ccccc2)c1SCc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.53
HSD17B10 Q99714 1/20 0.40
KMT2A Q03164 3/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
MAPT P10636 3/20 0.39
NPSR1 Q6W5P4 3/20 0.39
MEN1 O00255 2/20 0.39
PKM P14618 2/20 0.39
PTPRC P08575 1/20 0.39
CA12 O43570 2/20 0.38
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
CA7 P43166 1/20 0.38
CA13 Q8N1Q1 1/20 0.38
SLC6A4 P31645 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.36
ALDH1A1 P00352 3/20 0.36
LMNA P02545 3/20 0.36
PPARG P37231 3/20 0.36
NCOA2 Q15596 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2929900 0.84 POLB (0.61) POLBHSD17B10KMT2AL3MBTL1MAPT
SCHEMBL4745187 0.80 POLB (0.45) POLBHSD17B10KMT2AL3MBTL1MAPT
SCHEMBL9118538 0.80 POLB (0.59) POLBHSD17B10KMT2AL3MBTL1MAPT
SCHEMBL15953118 0.79 POLB (0.55) POLBHSD17B10KMT2AL3MBTL1MAPT
SCHEMBL16670318 0.79 POLB (0.55) POLBHSD17B10KMT2AL3MBTL1MAPT
SCHEMBL8373225 0.78 POLB (0.53) POLBHSD17B10KMT2AL3MBTL1MAPT
SCHEMBL16670248 0.76 POLB (0.52) POLBHSD17B10KMT2AL3MBTL1MAPT
SCHEMBL367099 0.75 POLB (0.56) POLBHSD17B10KMT2AL3MBTL1MAPT
SCHEMBL1576666 0.74 POLB (0.49) POLBHSD17B10KMT2AL3MBTL1MAPT
SCHEMBL17223627 0.74 POLB (0.49) POLBHSD17B10KMT2AL3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1891106-A2 NOVEL COMPOUNDS AS GLP-I AGONISTS CADILA HEALTHCARE LTD. (IN) 2008-02-27 EP claimed
WO-2007017892-A2 NOVEL COMPOUNDS AS GLP-I AGONISTS CADILA HEALTHCARE LIMITED (IN) 2007-02-15 WO claimed
EP-1891106-A2 NOVEL COMPOUNDS AS GLP-I AGONISTS CADILA HEALTHCARE LTD. (IN) 2008-02-27 EP disclosed
WO-2007017892-A2 NOVEL COMPOUNDS AS GLP-I AGONISTS CADILA HEALTHCARE LIMITED (IN) 2007-02-15 WO disclosed